期刊文献+

PAI-1、胱抑素C与2型糖尿病大血管病变的相关性 被引量:2

原文传递
导出
摘要 随着经社会经济的发展,2型糖尿病患者的数量迅速增加,流行病学表明85%的2型糖尿病患者死于心脑血管等大血管并发症,其发生早、进展快、预后差,确切机制目前仍然不清楚。本文主要分析总结PAI-1、胱抑素C与2型糖尿病大血管病变的关系。
出处 《中国实用医刊》 2012年第9期94-95,共2页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献22

  • 1Eddy AA. Serine proteases,inhibitors and receptors in renal fibrosis[J].Thrombosis and Haemostasis,2009,(04):656-664.
  • 2Cale JM,Lawrence DA. Structure-function relationships of plasmino-gen activator inhibitor-1 and its potential as a therapeutic agent[J].Current Drug Targets,2007,(09):971-981.
  • 3张宏,王星冀,段贵芬,张卫.胱抑素C的临床应用评价[J].河北医药,2010,32(17):2413-2414. 被引量:5
  • 4Furumoto T,Fujii S,Sinto N. Relationships between branchial artery flow mediated dilation and crotid artery intimic-media thickness in patients with suspected coronary artery disease[J].Jan Heart J,2002,(02):117-125.
  • 5Arenillas JF,Alvarez-Sabin J,Molina CA. Progression of symptomatic intracranial large artery a therosclerosis is associated with a proinflammatory state and impaired fibrinolysis[J].Stroke,2008,(05):1456-1463.
  • 6Robbie LA,Booty NA,Brown A J. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque[J].Arterioscler Thromb Vasa Biol,1996,(04):539-545.
  • 7徐志强,王骏,王鸣和.胱抑素C与冠心病相关性的研究进展[J].心血管病学进展,2008,29(1):64-67. 被引量:36
  • 8Eriksson P,Deguchi H,Samnegard A. Human evidence that the Cystatin c gene is implicated in focal progression of coronary artery disease[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2004,(03):551-557.
  • 9Sukhova GK,Wang B,Libby P. Cystatin c deficiency inereaes elastic lamina degradation and aortic dilatation in apolipopmein in E nullmice[J].Circulation Research,2005,(03):368-375.
  • 10Abisi S,Bumand KG,Wahham M. Cysteine protease activity in the wall of abdominal aortic aneurysms[J].Journal of Vascular Surgery,2007,(06):1260-1266.doi:10.1016/j.jvs.2007.08.015.

二级参考文献48

  • 1陈瑞陶.脑血管病急性期尿素氮的改变[J].中国神经精神疾病杂志,1994,20(5):299-301. 被引量:14
  • 2史清海,路西春.胱抑素C的生物学特性及其测定的临床应用[J].西北国防医学杂志,2005,26(6):445-447. 被引量:33
  • 3郭富强,叶长林,刘洁.低血清胆红素与脑梗塞的关系[J].临床神经病学杂志,1996,9(6):336-338. 被引量:12
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33093
  • 5Janowski R,Kozak M,Jankowska E,et al.Human cystatin C,an amyloidogenic proein,dimerizes through three-dimensional domain swapping.Nat Strucr Biol,2001,8:316-320.
  • 6Dharnidharka VR,Kwon C,Stevens G.Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-a-nalysis.Am J Kidney Dis,2002,40:221-226.
  • 7Grubb A,Simonsen O,Sturfelt G,et al.Serum concentration of cystatin C,factor D and 2-microglobulin as a measure of glomerular filtration rate.Acts Med Scand,1995,218:499.
  • 8Randers E,Kristensen JH,Erlandsen EJ,et al.Serum cystatin C as a marker of the renal function.Scand J Clin Lab Invest,1998,58:585.
  • 9Kyhse-Andersen J,Schmidt C,Nordin G,et al.Serum cystatin C,determinde by a rapid,automated particle-enhanced trubidimeteric method,is a better marker than serum creatinine for glomenrular filtration rate.Clin Chem,1994,40:1921.
  • 10Newman DJ,Thakkar H,Edwards RG,et al.Serum cystatin C:a replacement for creatinine as a biochemical marker for GFR.Kidney Int,1997,46:20.

共引文献74

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部